Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
BOLT
$3.51
+0.31%
BOLT
· Bolt Biotherapeutics, Inc.
$3.51
+0.01 (+0.31%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company believes that this raises substantial doubt about its ability to continue as a going concern within one year after the issuance of the unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 11, 2026
Market Cap
$6.93M
Shares
1.93M
Volume · Oct 6
13.18K
Avg daily vol (3M)
25.22K
All webcasts
Earnings call · FY2021 Q3
Bolt Biotherapeutics, Inc. (BOLT) Q3 2021 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$752,000
Diluted EPS
-$12.60
Net income
-$23.39M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 9, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 9, 2021 · complete as-filed document